←
akerotx290 posts
akerotx avatar

akerotx

@akerotx

Advancing transformational new medicines that restore metabolic balance to treat serious metabolic diseases.

◷ Joined June 2018▧ 201 Photos and videos
akerotx avatar
akerotx@akerotx·Jan 5

As we welcome a new year, we’re reminded of the importance of progress, resilience, and our ongoing commitment to advancing research and therapies to transform the lives of people living with serious metabolic diseases. Wishing you a healthy, hopeful, and inspiring start to 2026!

akerotx avatar
akerotx@akerotx·23 Dec 2025

From our team to yours, Happy Holidays! We’re proud of what we accomplished together this year and grateful for the people who make it all possible. Wishing you all a joyous and restful holiday season.

akerotx avatar
akerotx@akerotx·22 Dec 2025

As 2025 comes to a close, we’re grateful for the dedication of our team, partners, investigators, patients, and advocates who propelled #TeamAkero forward. Looking ahead to 2026, we are energized by the momentum behind our science, our team, and our commitment to patients.

akerotx avatar
akerotx@akerotx·25 Nov 2025

A huge shoutout to our team for an inspiring series of offsite gatherings over the past few weeks! The creativity and commitment across our organization remind us how much we can accomplish when we’re aligned and inspired by a shared purpose. #TeamAkero #Biotech #MASH

Post attachmentPost attachmentPost attachmentPost attachment
akerotx avatar
akerotx@akerotx·17 Nov 2025

This year’s @AASLD #TLM25 emphasized the novel research in MASH treatment. We were proud to share the latest efruxifermin data from SYMMETRY & HARMONY in 2 oral and 2 poster presentations. Our thanks and appreciation to the experts who are driving innovation in the field of MASH.

Post attachmentPost attachmentPost attachment
akerotx avatar
akerotx@akerotx·24 Oct 2025

This past weekend our team had the privilege of participating in the Liver Life Walk in San Francisco. Events like these remind us why we do what we do. A huge thank you to the @liverUSA for hosting and bringing the community together to drive progress for patients and families.

Post attachmentPost attachmentPost attachmentPost attachment
akerotx avatar
akerotx@akerotx·22 Oct 2025

A big thank you to our Clinical Development Team for an energizing offsite! This offsite gave us the chance to connect, reflect, and align around our shared mission to advance treatment options for MASH and MASLD. #Biotech #MASH #MASLD #TeamAkero

Post attachmentPost attachmentPost attachmentPost attachment
akerotx avatar
akerotx@akerotx·30 Sep 2025

Join us tomorrow at the @HansonWade 9th Annual #MASH Drug Development Summit as our Director of Translational Biology and Pharmacology, Erik Tillman, PhD, shares a talk highlighting #EFX’s anti-fibrotic effects corroborated by noninvasive biomarkers and serial-biopsies.

Post attachment
akerotx avatar
akerotx@akerotx·15 Sep 2025

Aging brings new reasons to act with intention. Metabolic diseases like MASLD and MASH can progress silently, but early action makes all the difference. At Akero, we’re committed to building a future where people can age with strength and clarity. #HealthyAgingMonth

Post attachment